vs
UiPath, Inc.（PATH）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是UiPath, Inc.的1.5倍（$603.8M vs $411.1M），UiPath, Inc.净利率更高（48.4% vs 0.6%，领先47.8%），Privia Health Group, Inc.同比增速更快（25.8% vs 15.9%），过去两年Privia Health Group, Inc.的营收复合增速更高（19.6% vs 0.7%）
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
PATH vs PRVA — 直观对比
营收规模更大
PRVA
是对方的1.5倍
$411.1M
营收增速更快
PRVA
高出9.9%
15.9%
净利率更高
PATH
高出47.8%
0.6%
两年增速更快
PRVA
近两年复合增速
0.7%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $411.1M | $603.8M |
| 净利润 | $198.8M | $3.7M |
| 毛利率 | 83.3% | 20.8% |
| 营业利润率 | 3.2% | 1.2% |
| 净利率 | 48.4% | 0.6% |
| 营收同比 | 15.9% | 25.8% |
| 净利润同比 | 1966.2% | -27.4% |
| 每股收益（稀释后） | $0.37 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PATHPRVA
| Q1 26 | — | $603.8M | ||
| Q4 25 | $411.1M | $541.2M | ||
| Q3 25 | $361.7M | $580.4M | ||
| Q2 25 | $356.6M | $521.2M | ||
| Q1 25 | $423.6M | $480.1M | ||
| Q4 24 | $354.7M | $460.9M | ||
| Q3 24 | $316.3M | $437.9M | ||
| Q2 24 | $335.1M | $422.3M |
净利润PATHPRVA
| Q1 26 | — | $3.7M | ||
| Q4 25 | $198.8M | $9.2M | ||
| Q3 25 | $1.6M | $6.9M | ||
| Q2 25 | $-22.6M | $2.7M | ||
| Q1 25 | $51.8M | $4.2M | ||
| Q4 24 | $-10.7M | $4.4M | ||
| Q3 24 | $-86.1M | $3.5M | ||
| Q2 24 | $-28.7M | $3.5M |
毛利率PATHPRVA
| Q1 26 | — | 20.8% | ||
| Q4 25 | 83.3% | — | ||
| Q3 25 | 82.2% | — | ||
| Q2 25 | 82.1% | — | ||
| Q1 25 | 84.8% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 80.0% | — | ||
| Q2 24 | 83.5% | — |
营业利润率PATHPRVA
| Q1 26 | — | 1.2% | ||
| Q4 25 | 3.2% | 2.1% | ||
| Q3 25 | -5.6% | 2.5% | ||
| Q2 25 | -4.6% | 0.6% | ||
| Q1 25 | 7.9% | 1.1% | ||
| Q4 24 | -12.2% | 1.1% | ||
| Q3 24 | -32.7% | 1.3% | ||
| Q2 24 | -14.8% | 1.2% |
净利率PATHPRVA
| Q1 26 | — | 0.6% | ||
| Q4 25 | 48.4% | 1.7% | ||
| Q3 25 | 0.4% | 1.2% | ||
| Q2 25 | -6.3% | 0.5% | ||
| Q1 25 | 12.2% | 0.9% | ||
| Q4 24 | -3.0% | 1.0% | ||
| Q3 24 | -27.2% | 0.8% | ||
| Q2 24 | -8.6% | 0.8% |
每股收益（稀释后）PATHPRVA
| Q1 26 | — | $0.02 | ||
| Q4 25 | $0.37 | $0.08 | ||
| Q3 25 | $0.00 | $0.05 | ||
| Q2 25 | $-0.04 | $0.02 | ||
| Q1 25 | $0.09 | $0.03 | ||
| Q4 24 | $-0.02 | $0.03 | ||
| Q3 24 | $-0.15 | $0.03 | ||
| Q2 24 | $-0.05 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $419.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $805.9M |
| 总资产 | $2.9B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PATHPRVA
| Q1 26 | — | $419.5M | ||
| Q4 25 | $1.4B | $479.7M | ||
| Q3 25 | $1.4B | $441.4M | ||
| Q2 25 | $1.6B | $390.1M | ||
| Q1 25 | $1.6B | $469.3M | ||
| Q4 24 | $1.6B | $491.1M | ||
| Q3 24 | $1.7B | $422.0M | ||
| Q2 24 | $1.9B | $387.4M |
股东权益PATHPRVA
| Q1 26 | — | $805.9M | ||
| Q4 25 | $1.9B | $737.2M | ||
| Q3 25 | $1.7B | $709.1M | ||
| Q2 25 | $1.7B | $682.9M | ||
| Q1 25 | $1.8B | $659.4M | ||
| Q4 24 | $1.7B | $635.2M | ||
| Q3 24 | $1.8B | $614.9M | ||
| Q2 24 | $2.0B | $595.4M |
总资产PATHPRVA
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.9B | $1.4B | ||
| Q3 25 | $2.6B | $1.4B | ||
| Q2 25 | $2.6B | $1.3B | ||
| Q1 25 | $2.9B | $1.2B | ||
| Q4 24 | $2.7B | $1.1B | ||
| Q3 24 | $2.7B | $1.1B | ||
| Q2 24 | $2.8B | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.3M | $-49.5M |
| 自由现金流经营现金流 - 资本支出 | $25.1M | — |
| 自由现金流率自由现金流/营收 | 6.1% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 0.14× | -13.33× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PATHPRVA
| Q1 26 | — | $-49.5M | ||
| Q4 25 | $28.3M | $127.5M | ||
| Q3 25 | $41.6M | $52.0M | ||
| Q2 25 | $119.0M | $8.0M | ||
| Q1 25 | $146.1M | $-24.1M | ||
| Q4 24 | $28.1M | $74.8M | ||
| Q3 24 | $46.4M | $33.2M | ||
| Q2 24 | $100.0M | $34.5M |
自由现金流PATHPRVA
| Q1 26 | — | — | ||
| Q4 25 | $25.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $106.2M | — | ||
| Q1 25 | $138.7M | — | ||
| Q4 24 | $23.2M | — | ||
| Q3 24 | $45.0M | — | ||
| Q2 24 | $98.8M | — |
自由现金流率PATHPRVA
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | 32.7% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 14.2% | — | ||
| Q2 24 | 29.5% | — |
资本支出强度PATHPRVA
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.4% | — |
现金转化率PATHPRVA
| Q1 26 | — | -13.33× | ||
| Q4 25 | 0.14× | 13.93× | ||
| Q3 25 | 26.25× | 7.58× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | 2.82× | -5.70× | ||
| Q4 24 | — | 17.00× | ||
| Q3 24 | — | 9.38× | ||
| Q2 24 | — | 9.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
PRVA
| FFS-patient care | $391.1M | 65% |
| Capitated revenue | $86.1M | 14% |
| Other | $75.0M | 12% |
| FFS-administrative services | $31.4M | 5% |
| Care management fees (PMPM) | $17.9M | 3% |
| Other revenue | $2.3M | 0% |
